<?xml version="1.0" encoding="UTF-8"?>
<p id="p0210">
 <italic>Patients without COVID-19:</italic> HCC surveillance can be deferred based on available resources (including availability of therapeutic options in case of HCC diagnosis) at the centre and the individual risk assessment. Patients with increased risk, such as patients with elevated alpha-fetoprotein levels, advanced cirrhosis, chronic hepatitis B, NASH/diabetes 
 <italic>etc.</italic>, may be prioritised if resources are limited.
</p>
